Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 3,356 shares at $59.43 ($199K) on 2025-02-04, disclosed to the SEC on 2025-02-04.
Seasonal sale ($199k) by Chief Financial Officer — this insider has traded RYTM in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.43 | 1,678 | $100K | 50.0% |
| 2 | $59.43 | 1,678 | $100K | 50.0% |
| Total | $59.43 avg | 3,356 | $199K | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |